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The Control of Allergic Rhinitis and Asthma Test (CARAT) 
was introduced to assess control of allergic rhinitis and asthma 
(ARA) simultaneously. It is the first tool to implement ARIA 
guidelines in clinical practice [1-5].
CARAT10 was developed for adults [5], and CARATKids 
was designed for children aged 6 to 12 years [6]. There is no 
validated questionnaire to assess control of ARA in patients 
between the ages of 12 to 17 years.
This study compares the psychometric properties of 
the 2 currently available questionnaires for assessment of control 
of ARA in a population of adolescents aged 12-17 years. 
Approval was obtained from the Ethics Committee of 
Braga Hospital and from the Ethics Committee of the School 
of Medicine of the University of Minho, Braga, Portugal.
A nonrandom consecutive sample of participants 
aged 12-17 years with a diagnosis of ARA was recruited 
from patients attending the Pediatric Allergology Clinic at 
Braga Hospital. Patients with other coexisting chronic or 
respiratory diseases that could influence the results were 
excluded.
The adolescents were asked to complete the Asthma Control 
Test (ACT) [7] and the CARAT10 [5] and CARATKids [6] 
questionnaires. Participants were assessed by their doctor, and 
the researcher conducted a short interview with the participants 
to assess the acceptability of the questionnaires. 
Medical assessment covered 6 parameters: (1) the 
classification of rhinitis as intermittent or persistent and mild 
or moderate/severe, as described in the ARIA guidelines; 
(2) a 10-cm visual analog scale (VAS, from 1 to 10) for rating 
disease control in the previous 4 weeks; (3) a classification of 
asthma control, according to the GINA criteria, as controlled, 
partly controlled, and uncontrolled; (4) a VAS for rating disease 
control in the previous 4 weeks; (5) atopy; and (6) treatment.
Categorical variables were expressed as absolute and 
relative frequencies. The Pearson or Spearman and intraclass 
correlation coefficient (ICC) were used to study the correlation 
and agreement between the CARAT and ACT scales and the 
CARAT and the medical evaluation, which included the VAS 
scores and the ARIA and GINA classifications.
The study included 103 patients (64% males). The most 
frequent comorbidities were a personal and/or family history 
of atopy. 
Associations between the questionnaires and the medical 
evaluation were lower than expected (Pearson correlation 
r <0.40, and ICC <0.5). The correlation between the CARAT10 
scores and VAS scores for the 14-15 and 16-17 year groups 
met the a priori prediction (r >0.40). No significant differences 
were found for the associations between questionnaires and the 
medical evaluation before and after the consultation. Similarly, 
no association was found with the parents’ level of education.
Most participants (62%) said they preferred CARATKids to 
CARAT10. They found it easier to complete (36 participants), 
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Figure. Receiver operating characteristic curves of the ACT with CARAT 
and with CARATKids.
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faster to complete (14 participants), more appealing 
(7 participants), more complete, and more user-friendly than 
the CARAT10. 
The results suggest that both CARAT10 and CARATKids 
can be used to assess the control of asthma in patients aged 
12 to 17 years. The CARAT10 questionnaire can be used in 
patients from age 14 years to evaluate control of ARA.
The correlation coefficients met the a priori predictions 
for these instruments, suggesting that they can be used 
to evaluate the control of asthma in this population. The 
CARAT10a subscore had a higher correlation with the ACT, 
as expected, because, like the ACT, it only assesses the control 
of asthma, while CARATKids assesses the control of ARA. 
Our results favor the use of CARAT10 among patients aged 
14 to 17 years [8].
ROC curves were constructed for the CARATKids and 
CARAT10 scores against the ACT (Figure). For adolescents, 
new cut-off values for these questionnaires may need to be 
considered. For CARATKids, we suggest a cut-off score of 
>6 points for uncontrolled asthma, with a sensitivity of 91% 
and a specificity of 65%. This is in agreement with previous 
proposals for this questionnaire [6]. 
For CARAT10, ROC curves were also analyzed in relation 
to the medical VAS assessment. A cut-off value of 21 indicated 
the best balance between sensitivity and specificity.
CARAT10 can be used for the evaluation of ARA 
in patients aged 14 years and onward. CARATKids and 
CARAT10 may both be used for the evaluation of asthma in 
patients aged 12 to 17 years. Further studies are needed to 
assess whether new cut-off values should be established for 
patients aged 14 to 17 years.
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